The emerging therapy of this peptide represents a significant development in the management of type 2 diabetes. Different to existing medications, tirzepatide affects two pathways – the GLP-1 hormone and the GIP https://tirzepatidepeptide489895.digiblogbox.com/66473419/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment